Abstract:ID 93611 Poster Board 502 Methamphetamine abuse amongst adolescents has been on the rise in the United States. Exposure to methamphetamine followed by withdrawal can lead to sensitization of brain circuits, which can promote continued abuse of methamphetamine. However, neural substrates underlying methamphetamine-induced sensitization in adolescents has not been fully explored. In this study, we focused on the behavioral effects of methamphetamine in male and female adolescent rats with a history of methamphetamine exposure and kappa opioid receptors (KOR) manipulation. Adolescent male and female rats (approx. 4 weeks of age) were used in the study, which was conducted over 28 days. All animals were treated with saline on Day 1 to assess baseline locomotor activity and to habituate the animals to the locomotor activity chambers. Methamphetamine (0.5 mg/kg; i.p.) induced locomotor activity (primary dependent measure) was measured on Days 2 and 28 in all animals irrespective of treatment between Days 3-8 (period of intermittent repeated methamphetamine exposure). After assessment of methamphetamine-induced locomotor activity on Day 2, male and female adolescent rats were divided into three groups: Group one animals received an injection saline (1 ml/kg; s.c.; control) 30 minutes prior to treatment with methamphetamine (1 mg/kg; i,p,) daily for 6 days (Days 3-8); Group two animals received an injection of the KOR agonist (U50488; 6 mg/kg; s.c.) 30 minutes prior to treatment with methamphetamine (1 mg/kg; i,p,) daily for 6 days (Days 3-8); Group 3 animals received the KOR antagonist (norBNI; 15 mg/kg; s.c.) on Day 2 approximately four hours after measurement of methamphetamine (0.5 mg/kg; i.p.)-induced locomotor activity. Subsequently, all Group 3 animals were treated with an injection of methamphetamine (1 mg/kg; i,p,) daily for 6 days (Days 3-8). Animals received only one injection of the KOR antagonist (norBNI) because of its long duration of action. Animals received no methamphetamine treatment between Days 9-27 (drug-free/ withdrawal period). This drug-free period has been hypothesized to alter brain circuits resulting in sensitized responses to methamphetamine. Blockade of the KORs prior to methamphetamine (1 mg/kg) exposure (Days 3-8; Group 3) significantly increased methamphetamine-induced locomotor activity [measured as percentage of baseline (Day 2)] in adolescent male rats, but not female rats, compared to respective saline controls (Group 1). However, there was no significant difference in methamphetamine-induced locomotor activity on Day 28 [measured as percentage of baseline (Day 2)] in either male or female adolescent rats treated with the KOR agonist during methamphetamine (1 mg/kg) exposure (Days 3-8; Group 2) compared to respective saline controls (Group 1). Based on the data we can suggest an underlying inhibitory role of the KORs on methamphetamine-induced locomotor activity in adolescent male rats, which was unmasked by blocking KORs prior to methamphetamine (1 mg/kg) exposure. Previously, we had reported similar effects of blockade of the KORs on methamphetamine-induced locomotor activity in adult male, but not female, rats. Together, the data suggest a sex-dependent differential role for the KORs on methamphetamine-induced locomotor activity in adolescent male and female rats with a history of methamphetamine exposure and KOR manipulation. Supported by Endowed Pharmacy Centennial Research Award, Raabe College of Pharmacy and Ohio Northern University

MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems

Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects

Neonatal MK-801 treatment differentially alters the effect of adolescent or adult MK-801 challenge on locomotion and PPI in male and female rats.

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Age-related Differential Sensitivity to MK-801-induced Locomotion and Stereotypy in C57BL/6 Mice.

Importance of dopaminergic neurotransmission for the RU 24969–induced locomotor activity of male and female rats during the preweanling period

Bimodal Effects of MK-801 on Locomotion and Stereotypy in C57BL/6 Mice

The effects of neonatal MK-801 treatment on expression of NMDA receptors and NGF in rats

Age-specific effects of early MK-801 treatment on working memory in female rats.

Effects of acute treatment of dizocilpine maleate on locomotor activity, prepulse inhibition and object recognition memory in rats n

Sex differences and influence of gonadal hormones on MK801-induced neuronal degeneration in the granular retrosplenial cortex of the rat

Age-dependent Effects of (+)-MK801 Treatment on Glutamate Release and Metabolism in the Rat Medial Prefrontal Cortex

Paradoxical Effects of Very Low Dose Mk-801

NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism and Semaphorin Signaling in Rats: a Synaptic Proteome Study.

Enhanced interaction among ErbB4, PSD-95 and NMDAR by chronic MK-801 treatment is associated with behavioral abnormalities.

Sex-specific effects of subchronic NMDA receptor antagonist MK-801 treatment on hippocampal gamma oscillations

Differential sex-dependent behavioral effects of methamphetamine in adolescent rats with a history of methamphetamine exposure and kappa opioid receptor manipulation

Long-term effects of MK-801 administration during brain development on cognitive function and cerebral expression of NMDA receptors in rats

Use of Quantitative Electroencephalography to Inform Age- and Sex-Related Differences in NMDA Receptor Function following MK-801 Administration

Postnatal BDNF Expression Profiles in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by MK-801 Administration

NMDA Receptor Antagonists Reduce Restraint-Induced Release of Prolactin in Male Rats.